ResMed Inc. sees increased institutional investment in Q2

ResMed Inc., a global medical equipment provider specializing in sleep apnea treatments and SaaS solutions, has seen significant activity from institutional investors. During the second quarter, Handelsbanken Fonder AB increased its position in the company by 36.6%, bringing its total holdings to 94,895 shares valued at approximately $18.5 million.

Other notable increases in holdings during the same period include Assenagon Asset Management S. A., which grew its position by 48.2%, and the Czech National Bank, which raised its stake by 4.1%.

Despite recent fluctuations in share price, ResMed maintains a broad global presence with over 10,000 employees operating in more than 140 countries. The company operates through two primary units: Sleep and Respiratory Care, which provides CPAP machines and ventilation systems, and a Software as a Service (SaaS) unit focused on out-of-hospital care data.